Literature DB >> 2131166

Inflammatory bowel diseases and thymus disorder: reactivity of thymocytes with monoclonal antibodies.

Y Mizuno1, M Muraoka, K Shimabukuro, K Toda, K Miyagawa, H Yoshimatsu, M Tsuchiya.   

Abstract

Thymectomy is one of the most effective means of treating myasthenia gravis (MG). Formation of lymphoid follicles in the thymus is seen at high rate in ulcerative colitis (UC) as well as MG. We examined the subsets of lymphocytes in the thymuses taken from patients with inflammatory bowel diseases (IBD), using OK series monoclonal antibodies. Decreases in OKT8 (CD8)-, 6(CD1)- and 10-positive cells and an increase of IA1-positive cells were observed in UC. In contrast, there were no significant changes in Crohn's disease (CD). Therefore, the thymocytes from UC appear to consist of comparatively matured cells under the influence of thymic hormone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2131166

Source DB:  PubMed          Journal:  Bull Tokyo Dent Coll        ISSN: 0040-8891


  3 in total

1.  Associated thyreoiditis, myasthenia gravis, thymectomy, Chron's disease, and erythema nodosum: pathogenetic and clinical correlations, immune system involvement, and systemic infectious complications.

Authors:  Roberto Manfredi; Giovanni Fasulo; Ciro Fulgaro; Sergio Sabbatani
Journal:  Rheumatol Int       Date:  2008-04-04       Impact factor: 2.631

2.  Crohn's disease and myasthenia gravis: a possible role for thymectomy.

Authors:  I A Finnie; R Shields; R Sutton; R Donnelly; A I Morris
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 3.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.